{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:15:13Z","timestamp":1770743713284,"version":"3.49.0"},"reference-count":23,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Aims:\u00a0This study aimed to evaluate whether the pan-immune inflammation value (PIV) has prognostic value for major adverse cardiac events (MACEs), including stroke, rehospitalization, and in-hospital and one-year all-cause mortality, in patients with aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI). Methods: A total of 152 patients undergoing TAVI were retrospectively analyzed and stratified into two groups based on a PIV cutoff value of 488. Baseline clinical, laboratory, echocardiographic, and procedural characteristics were compared. Clinical outcomes, including mortality, cerebrovascular events, and bleeding complications, were assessed. Multivariable logistic regression and receiver operating characteristic (ROC) curve analyses were performed to identify independent mortality predictors and evaluate the predictive performance of PIV. Results: Among the 152 patients (mean age 77 \u00b1 7 years; 59.9% female), 52 (34.2%) had a PIV \u2265 488. These patients had significantly higher rates of diabetes mellitus (62% vs. 38%, p = 0.006), chronic kidney disease (31% vs. 12%, p = 0.005), and chronic obstructive lung disease (31% vs. 15%, p = 0.022), along with higher STS scores (16.3 vs. 11.7, p = 0.003). Inflammatory markers were elevated, and lymphocyte and hemoglobin levels were reduced in the high PIV group (p &lt; 0.001). Patients with PIV \u2265 488 experienced significantly higher one-year mortality (58% vs. 4%, p &lt; 0.001), in-hospital mortality (21% vs. 2%, p &lt; 0.001), rehospitalization (29% vs. 4%, p &lt; 0.001), ischemic cerebrovascular events (12% vs. 4%, p &lt; 0.001), and major bleeding (10% vs. 2%, p = 0.034). Multivariable analysis identified age (OR: 1.108; 95% CI: 1.010\u20131.217; p = 0.031) and PIV (OR: 1.006; 95% CI: 1.003\u20131.008; p &lt; 0.001) as independent mortality predictors. The PIV showed a strong predictive performance (AUC: 0.90, p &lt; 0.001), with 88% sensitivity and 81% specificity. Kaplan\u2013Meier analysis showed significantly lower survival in the high PIV group (p &lt; 0.001). Conclusions: A high preprocedural PIV is an independent predictor of MACEs, in-hospital, and one-year mortality in AS patients undergoing TAVI.<\/jats:p>","DOI":"10.3390\/medicina61060992","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T07:46:26Z","timestamp":1748504786000},"page":"992","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Value of Pan-Immune Inflammation Value for Major Adverse Cardiac Events and Mortality in Patients with Aortic Stenosis After TAVI"],"prefix":"10.3390","volume":"61","author":[{"given":"Mehmet Nail","family":"Bilen","sequence":"first","affiliation":[{"name":"Department of Cardiology, Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul 34000, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1535-5168","authenticated-orcid":false,"given":"Mehmet Rasih","family":"Sons\u00f6z","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul 34000, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1054-2455","authenticated-orcid":false,"given":"Yusuf","family":"\u0130nci","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul 34000, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeliz","family":"G\u00fcler","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul 34000, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"G\u00fcler","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul 34000, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8882-2951","authenticated-orcid":false,"given":"Hamdi","family":"P\u00fc\u015f\u00fcro\u011flu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul 34000, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"ref_1","first-page":"104","article-title":"2020 ACC\/AHA Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"141","author":"Otto","year":"2020","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients","volume":"380","author":"Mack","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients","volume":"374","author":"Leon","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and Atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.cjca.2014.03.029","article-title":"Basic Mechanisms of Calcific Aortic Valve Disease","volume":"30","author":"Mathieu","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.amjcard.2008.05.006","article-title":"Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome","volume":"102","author":"Tamhane","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/0003319713480424","article-title":"Association between coronary artery ectasia and neutrophil\u2013lymphocyte ratio","volume":"64","author":"Balta","year":"2013","journal-title":"Angiology"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kuang, T., Qiu, Z., Wang, K., Zhang, L., Dong, K., and Wang, W. (2024). Pan-immune inflammation value as a prognostic biomarker for cancer patients treated with immune checkpoint inhibitors. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1326083"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e13872","DOI":"10.1111\/eci.13872","article-title":"Comparison of pan-immune-inflammation value with other inflammation markers of long-term survival afterST-segment elevation myocardial infarction","volume":"53","author":"Murat","year":"2023","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"VARC-3 Writing Committee, G\u00e9n\u00e9reux, P., Piazza, N., Alu, M.C., Nazif, T., Hahn, R.T., Pibarot, P., Bax, J.J., A Leipsic, J., and Blanke, P. (2021). Valve Academic Research Consortium 3: Updated endpoint definitions for aortic valve clinical research. Eur. Heart J., 42, 1825\u20131857.","DOI":"10.1093\/eurheartj\/ehaa799"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"RRecommendations for quantitation of the left ventricle by two-dimensional echocardiography","volume":"2","author":"Schiller","year":"1989","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2016.09.089","article-title":"Patients with calcific aortic stenosis exhibit systemic molecular evidence of ischemia, enhanced coagulation, oxidative stress and impaired cholesterol transport","volume":"225","author":"Sanchez","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1010-7940(99)00134-7","article-title":"European system for cardiac operative risk evaluation (EuroSCORE)","volume":"16","author":"Nashef","year":"1999","journal-title":"Eur. J. Cardio-Thoracic Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jcin.2009.07.005","article-title":"Transcatheter aortic valve implantation: Review of the nature, management, and avoidance of procedural complications","volume":"2","author":"Masson","year":"2009","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.athoracsur.2009.04.059","article-title":"Society of thoracic surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement","volume":"88","author":"Wendt","year":"2009","journal-title":"Ann. Thorac. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/jocs.14499","article-title":"Prognostic impact of baseline C-reactive protein levels on mortality after transcatheter aortic valve implantation","volume":"35","author":"Takagi","year":"2020","journal-title":"J. Card. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0002-9149(96)00878-8","article-title":"Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease","volume":"79","author":"Ommen","year":"1997","journal-title":"Am. J. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijcard.2016.08.260","article-title":"Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) can risk stratify patients in transcatheter aortic-valve replacement (TAVR)","volume":"223","author":"Condado","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e007213","DOI":"10.1161\/CIRCINTERVENTIONS.118.007213","article-title":"Prognostic Value of hs-CRP After Transcatheter Aortic Valve Implantation","volume":"11","year":"2018","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Tosu, A.R., Kalyoncuoglu, M., Biter, H.I., Cakal, S., Selcuk, M., \u00c7inar, T., Belen, E., and Can, M.M. (2021). Prognostic value of systemic immune-inflammation index for major adverse cardiac events and mortality in severe aortic stenosis patients after TAVI. Medicina, 57.","DOI":"10.3390\/medicina57060588"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.clinbiochem.2017.11.008","article-title":"Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: A systematic review and meta-analysis","volume":"52","author":"Dong","year":"2018","journal-title":"Clin. Biochem."},{"key":"ref_23","first-page":"e20240286","article-title":"Inflammation and prognosis in acute heart failure: Is there a role for pan-immune-inflammation value?","volume":"121","author":"Villacorta","year":"2024","journal-title":"Arq. Bras Cardiol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/6\/992\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:41:21Z","timestamp":1760031681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/6\/992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["medicina61060992"],"URL":"https:\/\/doi.org\/10.3390\/medicina61060992","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]}}}